Analystreport

TCR2 Therapeutics Inc. (NASDAQ: TCRR) had its price target lowered by analysts at HC Wainwright from $19.00 to $14.00.

TCR2 Therapeutics Inc.  (TCRR) 
Last tcr2 therapeutics inc. earnings: 11/12 07:00 am Check Earnings Report